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Foveal pathway visual function was assessed in 11 patients having tumours extending into the
suprasellar region but without evidence of visual impairment as assessed by visual acuity and
Bjerrum screen campimetry. Psychophysical and routine visual evoked potential (VEP) measure-
ments were obtained from the eye ipsilateral to the maximal suprasellar extension. The sensitivity
of luminance and chromatic pathways was assessed psychophysically by measuring increment
thresholds for white and red flashes of light presented on a white adapting field. Temporal
sensitivity was assessed psychophysically by measuring threshold modulation sensitivity for
sinusoidally modulating stimuli (de Lange attenuation characteristic). The patient group showed
approximately equal significant psychophysical losses in chromatic, luminance and temporal
sensitivities relative to normal controls. Midline VEP P100 latencies of the patient group did not
significantly differ from those of the normal control group. It is concluded that tumours extending
into the suprasellar region can cause foveal pathway dysfunction affecting both magno- and parvo-
cellular pathways, even in the presence of normal visual acuity and fields suggesting a more
widespread and insidious abnormality of the visual pathways in this condition than previously
thought.*C 1997 Elsevier Science Ltd. All rights reserved.
Fovea Magnocellular Parvocellular Chiasm dysfunction
INTRODUCTION
Tumours affecting the suprasellar region, such as
pituitary adenomas, craniopharyngiomas and meningio-
mas, grow slowly usually producing insidiously progres-
sive visual field deficits which are variations on a
bitemporal theme. Usually only at advanced stages is
visual acuity reduced (Glaser, 1990). The inferior aspect
of the chiasm is situated 8–13 mm above the naso-
tuberculum line (i.e., the plane of the diaphragm sellae or
clinoid processes); therefore tumours must extend well
above the sella turcica and into the suprasellar region to
contact the chiasm (Glaser, 1990). The mechanism for
visual dysfunction produced by tumours extending into
the suprasellar region is unclear, the most likely causes
being either a direct compression of visual fibres or
interference with their vasculature; other possibilities are
changes in metabolites, trophic factors or proteases
associated with a developing neoplasm in the immediate
microenvironment.
There is evidence from animal studies of the effect of
direct compression on the anterior visual system,
although there are conflicting reports of which fibre type
is most susceptible. Reese and Cowey (1989) found that a
suprasellar meningioma in a macaque monkey, which
compressed the optic nerves, chiasm and tracts dorsally,
caused a selective loss of smaller-diameter (parvocellu-
lar) fibres; whereas, in the cat, optic nerve pressure block
has been shown to selectively disrupt large-diameter
(magnocellular) fibres (Burke et al., 1986).
The case for disruption to the vascular supply of the
chiasm by suprasellar lesions was made in a study of 480
human brain specimens by Bergland and Ray (1969). It
was found that the chiasmal arterial supply is divided into
superior and inferior vessel groups and that the central
portion of the chiasm derives its blood supply from only
the inferior vessels. Therefore, a disturbance of the
inferior vessels by a suprasellar lesion would account for
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the bitemporal field defects commonly seen in these
lesions. Alternatively, stretching of the crossing fibres
could account for the visual impairment (Glaser, 1990).
Whichever mechanism for anterior visual dysfunction
in suprasellar neoplastic lesions is entertained, the
peripheral bitemporal visual field would probably show
the greatest visual loss but foveal pathway function,
particularly the crossed foveal projection, might show
subclinical abnormalities. However, there have been
reports of lesions extending into the suprasellar region
failing to produce a field defect, but in the presence of
visual pathway dysfunction detected by abnormal VEP
waveform or latency (Gott et al., 1979; Pullan et al.,
1985). Therefore, the presence of clinically normal visual
fields does not preclude the possibility of abnormalities
of foveal function.
Assessment of foveal function by specific psychophy-
sical measures in patients having tumours extending into
the suprasellar region with otherwise normal visual
acuity and fields might help to answer the following
questions. First, is the assumption correct that foveal
function is unaffected in such cases? Second, if foveal
function is affected, which pathway is likely to be
involved?
Anatomically and functionally the anterior visual
pathway can be divided into the parvocellular and
magnocellular streams (Livingstone & Hubel, 1987;
Lee & Stromeyer, 1989; Merigan & Maunsell, 1990;
Schiller et al., 1990; Kolb, 1991; Merigan et al., 1991).
The magnocellular pathway arises from large retinal
ganglion cells (M-cells) and constitutes *10% of the
total number of optic nerve fibres (Silveira & Perry,
1991). It is assumed to detect luminance or achromatic
stimuli of low-to-medium spatial frequency. The parvo-
cellular pathway arises from small retinal ganglion cells
(P-cells) and gives rise to *80% of the total number of
optic nerve fibres (the remaining 10% projecting to mid-
brain structures). It is assumed to detect chromatic stimuli
of low-to-medium spatial frequency and achromatic
stimuli of high spatial frequency, therefore performing
a double duty (Ingling & Martinez-Uriegas, 1983, 1985;
Merigan & Maunsell, 1990; Merigan et al., 1991). At the
cortex, the division between these two pathways is not
completely maintained (Ferrera et al., 1992).
In this study, the foveal function of 11 patients having
tumours extending into the suprasellar region but with
normal visual acuity and fields was assessed by
psychophysical measures of luminance and chromatic
sensitivity and temporal contrast sensitivity (the de Lange
attenuation characteristic; de Lange, 1958), and by
conventional VEP recordings.
METHODS
Luminance and chromatic thresholds
Psychophysical measures were performed with a
modified visual perimeter. The system, which was
controlled by a laboratory microcomputer, was similar
to that described previously (Foster et al., 1985). The
subject was seated with a headrest, 1.2 m from the
perimeter screen. Observations were performed mono-
cularly; the other eye was occluded with an eye-patch.
Normal pupils were used by all subjects. An artificial
pupil was not used. Patients were examined for refractive
errors and either wore their own spectacles or a suitable
lens was inserted into an eyepiece in front of the eye.
The circular stimulus flash, of angle subtense 0.25 deg,
duration 200 msec, particular spectral content (either
white, correlated colour temperature 3250 K, or red, cut-
on wavelength 622 nm) and variable luminance, ap-
peared superimposed on a steady, concentric, uniform,
white (correlated colour temperature 3250 K) auxiliary
field, of luminance 1.85 log cd.mÿ2 and variable subtense
(either 0.25 or 1.25 deg). It was located centrally in the
visual field. An additional, steady, concentric, uniform
white conditioning field, luminance 1.42 log cd.mÿ2 and
subtense 20 deg, was introduced to maintain a constant
state of retinal adaptation. The stimulus and conditioning
fields were both derived from a tungsten–halogen light
source. The subject initiated the stimulus by pressing a
switch on a push-button box connected to the micro-
computer.
Luminance and chromatic sensitivity were evaluated
using four separate stimulus conditions in which a red or
white flash was presented on either a large or small
(spatially coincident) auxiliary field (white flash–large
auxiliary; white flash–small auxiliary; red flash–large
auxiliary; red flash–small auxiliary). Previous studies of
opponent-colour channel isolation (Foster, 1981; Foster
& Snelgar, 1983; Zrenner, 1983; Foster et al., 1985)
indicate that an effectively edgeless (low-to-medium
spatial frequency) achromatic stimulus, as represented by
a white flash on the coextensive auxiliary field, was likely
to be mediated by the magnocellular pathway and an
effectively edgeless (low-to-medium spatial frequency)
chromatic stimulus (red flash) on the same coextensive
auxiliary field and a sharp-edged (high spatial frequency)
achromatic stimulus, defined by a white flash on the large
auxiliary field, were both more likely to be mediated by
the parvocellular pathway.
The subject was given practice trials before each of the
four experimental conditions and was instructed to
respond “yes” or “no” according to whether the stimulus
was seen or not. The threshold for each experimental
condition was based on 45 stimulus trials, including five
randomly placed “empty” trials that contained no
stimulus to provide an estimate of the false-alarm rate.
If more than one false alarm was produced on the empty
trials in each experimental condition the data from that
observer were discarded. Another indication of potential
false alarms looked for was a “yes” response to very low
stimulus levels. Again, if false positives were produced
then the data from that observer were discarded and the
experimental run repeated. The luminance level of the
stimulus was adjusted by the microcomputer during each
trial sequence using a hybrid adaptive technique (Taylor
& Creelman, 1967; Hall, 1981). The time taken to
complete the trial sequence for each experimental
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condition was 5–10 min. The four conditions were
measured separately in the order white flash–large
auxiliary, red flash–large auxiliary, white flash–small
auxiliary, and red flash–small auxiliary. Response scores
as a function of stimulus luminance were analysed using
a computer-based method which fitted a cumulative
Gaussian frequency-of-seeing curve to each set of data
(Foster & Bischof, 1987). The stimulus threshold was
defined as the level at which the stimulus was seen on
50% of trials.
de Lange attenuation characteristic
Temporal contrast sensitivity was determined using an
arrangement of stimulus and background fields in which
the 0.25 deg stimulus had a sinusoidal temporal profile
and appeared within a fixed, contiguous surround field
(inner diameter 0.25 deg, outer diameter 1.25 deg), of
luminance 2.0 log cd.mÿ2. The stimulus and surround
fields were produced by yellow light-emitting diodes
(peak emission wavelength 584 nm, half-height band-
width 26 nm), driven by a digital electronic system under
the control of the microcomputer. The large conditioning
field was identical to that used in the luminance and
chromatic threshold measurements. The luminance L(t)
of the stimulus varied as a function of time t according to
the relationship L(t) = a + b.cos(2pft), where a was the
mean (d.c.) light level (2.0 log cd.mÿ2), b was the
modulation depth, normally expressed as a percentage of
the mean a, and f was the temporal frequency. The total
duration of the stimulus was 2 sec. The stimulus started at
a random point on the sinusoidal profile so that any
luminance cues at the start or end of the stimulus were
randomised from trial to trial. Edgar (1988) found that
this arrangement produced identical temporal contrast
sensitivity curves to methods where modulation was
ramped on and off at the start and end of the stimulus,
respectively.
The subject was again given preliminary practice trials
at 8 Hz. The modulation depth of the stimulus was varied,
and the subject was instructed to say “yes” or “no”,
according to whether the stimulus appeared to be
flickering or steady. The temporal frequency was then
set to 2 Hz, the first of the range of values to be tested. A
temporal contrast threshold was obtained by varying the
modulation depth over 40 stimulus trials according to the
adaptive technique described earlier. Five “empty” trials,
in which the stimulus had a constant luminance value a,
were again inserted. This whole sequence of trials lasted
about 5 min. Temporal contrast thresholds were deter-
mined at temporal frequencies increasing in 3-Hz
increments, up to 29 Hz or until a threshold could no
longer be recorded because the stimulus appeared not to
flicker even at maximum modulation depth. At the end of
this series of measurements, the temporal contrast
threshold at 2 Hz was redetermined to test for possible
fatigue or practice effects. The data were analysed using
the computer-based method described earlier (Foster &
Bischof, 1987).
Hue discrimination
Hue discrimination was assessed with the Farnsworth–
Munsell 100-hue test (Farnsworth, 1943, 1957). The caps
were viewed in a light box which illuminated the caps
with white light, with correlated colour temperature
approximately 6500 K. Each subject’s error score was
computed in the usual way. Data were analysed to test for
polarity of error scores via the technique of Allan (1985)
which uses Fourier analysis to extract the amplitude and
phase of the second harmonic of the distribution of error
scores.
Visual evoked potentials
Pattern reversal VEPs were measured with a checker-
board stimulus generated by a Medelec Sensor ST10 and
displayed on a Hitachi television screen. The pattern was
reversed at 2 Hz. The test was performed monocularly,
the other eye being occluded with an eyepatch. The
subject was seated 1.7 m from the screen. The stimulus
field subtended 12 deg horizontal by 9 deg vertical at the
subject’s eye; the check size was 48 min arc. The
luminance of the dark squares was 1.3 log cd.mÿ2 and
of the white squares 2.9 log cd.mÿ2. The test was
performed in a darkened room but the background
luminance was not rigidly controlled. Recordings were
obtained using scalp-surface silver/silver chloride disc
electrodes. The mid-occipital electrode was placed 5 cm
above the inion and the left and right occipital electrodes
were situated 2.5 cm on either side. The time-locked
responses were recorded with a Medelec Sensor ER94a
averager with a sweep count of 64 and an analysis time of
300 msec. The recording had a band pass frequency of 1–
100 Hz.
Visual fields
Visual fields were plotted with a Bjerrum screen after
the method of Patterson and Heron (1980), where the
criteria for target detection are defined. The average
screen luminance was 0.5 log cd.mÿ2 and the luminance
of the white targets was 2.3 log cd.mÿ2. The Bjerrum
screen method was preferred for visual field assessment
because of its flexibility and reliability in assessing the
central 50 deg diameter region, although very mild
depression of sensitivity may not be detected. Other
methods of visual-field evaluation, including automatic
static perimetry and computer assisted perimetry, have
been compared with Goldman perimetry in pituitary
adenoma cases (Grochowicki et al., 1991; Cannavo et al.,
1992), and within the central 30 deg identical results have
been obtained (Grochowicki et al., 1991).
Subjects
There were two groups: patients and normal controls.
Informed consent was obtained from all. Details are as
follows.
Patient group. There were 11 patients (six female and
five male; age range 19–71 years, mean+ SD
37.3+ 19.9 years), each having had a computed tomo-
graphic (CT) scan with enhancement showing lesions
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extending into the suprasellar region (3 mm) but
without signs of clinical visual impairment. A gadoli-
nium-enhanced magnetic resonance scan was not
performed as the precise anatomical localization of the
tumour borders would not have clarified its physiological
significance in relation to visual function. Visual acuity
was Snellen 6/6 or better, with correction if necessary.
Visual fields were normal as assessed by Bjerrum
screen perimetry. All patients had normal pupillary and
oculomotor function; no patient had diabetes or glau-
coma.
VEPs and psychophysical tests were obtained before
surgery or radiotherapy. During the time of testing, four
patients were taking bromocriptine, one patient pergolide
and one patient replacement thyroxine and hydrocorti-
sone. No patient had an uncorrected hormonal deficiency.
The known duration of the lesion before testing ranged
from 2 to 132 months. The nature of the lesion in five
cases was a prolactinoma (prolactin9000 mU/l (normal
<80–280 mU/l), which responded to dopamine agonists
and in one case a craniopharyngioma based on CT
appearances.
In the remaining five cases histology became available
after testing, four of them receiving surgery. The first
patient, a 20-year-old man, had elevated prolactin and
growth-hormone levels which were uncontrolled by
bromocriptine, and headaches. He was found to have an
acidophil stem-cell adenoma. The second patient was a
21-year-old man who had a large non-functioning tumour
and borderline pituitary function. The tumour proved to
be a craniopharyngioma. The third patient was a 19-year-
old man with headaches and obvious acromegaly
attributable to a growth-hormone adenoma. The fourth
patient was a 46-year-old acromegalic woman uncon-
trolled by bromocriptine; histology again showed a
growth-hormone adenoma. The fifth patient, a 71-year-
old man, had a large non-functioning tumour and
panhypopituitarism. He refused surgery but accepted
radiotherapy. He later died of coronary artery disease. A
post mortem showed a non-functioning adenoma.
Owing to the length of time necessary for full
psychophysical testing of each subject (approximately
3 hr per eye), only the eye ipsilateral to maximal supra-
sellar extension as seen on CT scan was tested. VEPs
were measured from the same eye.
Control groups. For VEPs the control group consisted
of 16 healthy subjects with normal vision (seven male,
nine female, age range 18–55 years, mean 33.5+ 10.5
years). For psychophysical measures the control group
consisted of 11 healthy subjects with normal vision (four
male, seven female, age range 26–63 years, mean
37.8+ 10.5 years).
Statistical analysis
The majority of tests involved comparisons of mean
threshold levels or VEP latencies; independent t tests,
with pooled estimates of variance, were used in the
analysis.
RESULTS
Psychophysical measures
The group mean (+ SE) luminance and chromatic
threshold results for control and patient groups are shown
graphically in Fig. 1. Subject reliability was high, as
evident from the low false-alarm rate indicated by the
small number of false positives from the “empty” trials.
For the patient group, the mean increase in threshold,
compared with the control group, for the white–large
(achromatic) condition was 0.22 log cd.mÿ2 (t  2.7,
df  20, P< 0.05), for the white–small condition was
0.27 log cd.mÿ2 (t  2.3, df  20, P< 0.05), for the red–
large condition was 0.19 log cd.mÿ2 (t  2.1, df  20,
n.s.), and for the red–small (chromatic) condition was
0.24 log cd.mÿ2 (t  2.4, df  20, P< 0.05). Therefore,
relative to the control group, the patient group showed
approximately equal mean losses of luminance and
chromatic sensitivity. There was no statistically signifi-
cant correlation between these psychophysical thresholds
and the levels of prolactin, cortisol, or growth hormone in
the patient group [Pearson correlation coefficient r:
prolactin ranged from ÿ0.37 to 0.06; cortisol ranged
from ÿ0.01 to 0.42; growth hormone ranged from ÿ0.33
to ÿ0.16, df  9, P > 0.05 in each case (12 separate
correlations)].
The de Lange attenuation characteristic results are
shown graphically in Fig. 2. Mean threshold modulation
depths and standard errors for control and patient groups
are shown at each temporal frequency. The mean
differences (d) between the 2 Hz thresholds obtained at
the beginning and end of the sessions for the two groups
were as follows: control group d  0.013 log percent
(t  0.32, df  10, n.s.); patient group d  0.005 log per
cent (t  0.14, df  10, n.s.). The differences were very
small, confirming that no significant practice or fatigue
effects had occurred.
FIGURE 1. Mean luminance and chromatic threshold values for
control (open bars) and patient groups (hatched bars). The vertical lines
show standard errors of the mean. Mean thresholds are plotted for the
red and white spots presented on a large or small (spatially coincident)
white auxiliary field.
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In the patient group there were statistically significant
mean reductions in temporal contrast sensitivity, relative
to the control group, of 0.22–0.28 log percent (t  32.8,
df  20, P< 0.01) at all temporal frequencies from 2 to
29 Hz. There was no statistically significant correlation
between these thresholds for temporal contrast sensitivity
and the levels of prolactin, cortisol, or growth hormone in
the patient group. [Pearson correlation coefficient r:
prolactin ranged fromÿ0.05 to 0.24; cortisol ranged from
0.33 to 0.56; growth hormone ranged fromÿ0.45 to 0.30,
df  9, P > 0.05 in each case (33 separate correlations)].
The mean (+SE) error score on the 100-hue test for
the normal controls was 56.7+ 13.1 and for the pituitary
tumour patients 144.7+ 25.8. The increase in error score
of 88 was statistically significant (t  3.0, df  20,
P< 0.01). The normal control group did not have any
significant polarised 100-hue results. In the patient group,
two subjects showed significant polarity along the
tritanopic axis. The other nine patients had, on average,
raised 100-hue error scores but no significant polarity,
i.e., a non-selective loss in colour discrimination. In the
patient group, there was no statistically significant
correlation between 100-hue error score and the levels
of prolactin, cortisol, or growth hormone.
Visual evoked potentials
The patient group had a mean P100 latency of
108.0 msec which constituted a small (5.8 msec) but
non-significant (t  1.4, df  25, n.s.) increase relative to
the control group. The waveforms for the patient group
were normal.
DISCUSSION
The aim of the present study was the assessment of
psychophysical foveal pathway function in patients
having suprasellar lesions and normal visual acuity and
fields. The patient group showed approximately equal
(0.2–0.3 log units) and significant psychophysical losses
in chromatic, luminance and temporal sensitivities at the
fovea relative to the control group. The study was
performed before radiotherapy (Capo & Kupersmith,
1991) or surgery, each of which could influence visual
function in their own right. Studies in demyelinating
disease of the optic nerve (Foster et al., 1985; Travis &
Thompson, 1989; Dain et al., 1990; Grigsby et al., 1991;
Russell et al., 1991) have also shown equal losses of
luminance and chromatic function in the central foveal
pathway and this study used similar psychophysical
techniques as Foster et al. (1985). However, other studies
of demyelinating disease have reported either greater
luminance than chromatic losses (Alvarez et al., 1982;
Alvarez & King-Smith, 1984) or greater chromatic than
luminance losses (Fallowfield & Krauskopf, 1984;
Mullen & Plant, 1986). These differences in results
could be due either to different criteria for patient
selection or to the specific stimuli used to measure the
chromatic and luminance functions (Plant, 1991a).
Since this study has revealed foveal visual losses in
patients with lesions affecting the suprasellar region, it is
possible that future studies of the perifoveal region in
patients having similar lesions may also reveal changes,
as the fibres subserving the foveal region do not have a
definitive border (Reese & Ho, 1988; Naito, 1989; Plant
& Perry, 1990).
This study found no statistically significant correlation
between any of the psychophysical measures of visual
function and the hormonal levels of prolactin, cortisol
and growth hormone in the patient group. Though patient
numbers were small and therefore the power of each
correlation test was relatively low, no correlation was
significant at the P< 0.05 level. Therefore, it is unlikely
that changes in these hormonal levels could be the
primary cause for the losses in visual function. In
pathologies involving fluctuating levels of hormones
(for example diabetes), typically there is a loss of colour
discrimination along the tritanopic axis (Scase et al.,
1990). The majority of the patient group had a non-
selective loss in colour discrimination. Two of the 11
patients had a greater colour discrimination loss on the
tritanopic axis than on the red–green axis. This result
might have implicated a hormonal cause to the
discrimination loss but hormonal levels for these two
patients were within the normal range.
Routine neuro-ophthalmological functional evaluation
of pituitary tumours during treatment and follow-up has
been by either visual fields (Rush et al., 1990; Hudson et
al., 1991; Cannavo et al., 1992) or VEPs (mainly
waveform changes and prolonged latency) (Pullan et
al., 1985; Pietrangeli et al., 1991; Go¨kalp et al., 1992;
Zaaroor et al., 1993). Neither is specific for pathophy-
siology. Our data would suggest that supplementing these
tests with the psychophysical measures described here
will provide extra information on the patient’s vision.
Patients having tumours affecting the suprasellar
region are usually assumed to have normal foveal
pathway function in the presence of normal acuity and
fields, although VEPs have previously been reported to
FIGURE 2. Mean threshold modulation depth plotted against temporal
frequency (de Lange attenuation characteristics) for control (open
symbols) and patient groups (filled symbols). The vertical lines show
standard errors of the mean.
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be abnormal in some cases (Gott et al., 1979; Pullan et
al., 1985; Flanagan & Harding, 1988), and in other
pathological conditions it is known that fibre loss can be
relatively advanced in the presence of normal visual
fields (Quigley et al., 1982). The routine midline VEPs in
the patient group were delayed relative to the controls but
did not reach significance. The reason for these
differences in sensitivity may be due partly to different
functional measures occurring over different but over-
lapping regions of the visual field: psychophysical
measures were made from the central 0.25 deg diameter
region, VEPs from the central 1269 deg region, and
Bjerrum-screen fields from the central 50 deg diameter
region. Flanagan & Harding (1988) have interpreted their
VEP results from patients with compressive lesions of the
chiasm as reflecting selective damage to magnocellular
fibres. The results from the present study, however,
would suggest that parvocellular fibres serving the fovea
are damaged as well as magnocellular fibres.
Studies assessing spatial frequency sensitivity in
lesions affecting the suprasellar region have found altera-
tions either to be total (Grochowicki et al., 1990) or
limited to low-to-medium spatial frequencies only
(Kupersmith et al., 1982; Lorance et al., 1987), possibly
suggesting involvement of both magno- and parvo-
cellular pathways. In some cases it was found that spatial
frequency alterations were an early sign of visual
pathway dysfunction, although in others there was no
abnormality, even in the presence of visual field loss
(Grochowicki et al., 1990).
Plant (1985) measured temporal contrast sensitivity in
patients with chiasmal compression both before and after
surgery. He described one patient who had approximately
uniform loss in temporal contrast sensitivity and another
patient with a greater loss in sensitivity to low temporal
frequencies before surgery. Studies on temporal contrast
sensitivity measured with either small stimuli (0.25 deg,
Edgar et al., 1990) or high spatial frequency gratings
(Hess & Plant, 1983) in optic neuritis have revealed a
decrease in sensitivity at high temporal frequencies.
However, larger stimuli (1 deg, Edgar et al., 1990) or
gratings with a lower spatial frequency (Hess & Plant,
1983) have produced greater losses at medium and low
temporal frequency. Studies measuring the spatial and
temporal contrast sensitivity in patients with ischaemic
lesions of the optic radiations (Plant, 1986; Plant &
Wilkins, 1988) have revealed deficits maximal at low
temporal frequencies and high spatial frequencies (see
Plant, 1991b for a review). Since our patients produced a
different pattern of temporal frequency loss to patients
with optic neuritis or ischaemic lesions it would suggest
that the pattern of damage is different between these
pathologies.
Animal models based on direct compression of the
anterior visual pathway have produced conflicting
results. Burke et al. (1986) showed that pressure block
of the cat optic nerve affected mainly magnocellular
fibres by electrophysiological and morphological criteria,
but Reese and Cowey (1989) who studied the effect of a
sub-chiasmal meningioma in a macaque monkey found a
conspicuous retrograde retinal ganglion cell loss in the
central 8 mm (the nasal and dorsal areas being more
affected), of mainly parvocellular fibres.
The mechanism for visual dysfunction resulting from
tumours extending into the suprasellar region is unclear,
and other possibilities besides direct compression need to
be considered. Bergland and Ray (1969) argued strongly
that vascular disruption was implicated. The central
portion of the chiasm derives its blood supply only from
inferior vessels, making lesions below the chiasm (i.e.,
suprasellar) more likely to interfere with blood supply to
the central chiasm, causing visual dysfunction which
could affect the temporal region in a non-selective
manner.
It also seems possible that dysfunction could be
produced by an active neoplastic process causing changes
in neurotrophic and growth factors or an increase in toxic
metabolites and proteases. The mechanism for visual
dysfunction could therefore be multifactorial. Certainly
the psychophysical data indicating foveal pathway
dysfunction, affecting both magno- and parvo-cellular
pathways, when routine functional measures were
normal, would favour a non-discriminating and non-
catastrophic process for the macular region. However, the
degree of visual loss caused by this process may vary at
different eccentricities and has not been considered in
this study.
In conclusion, tumours which extend into the supra-
sellar region can cause foveal pathway dysfunction
affecting both magno- and parvo-cellular pathways, even
in the presence of normal visual acuity and Bjerrum
fields, suggesting an undefined but more widespread and
insidious abnormality of the visual pathways in this
condition than previously thought.
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